BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus | Nature Communications
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies: Trends in Molecular Medicine
Frontiers | B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice | Medicine
Belimumab | SpringerLink
Mechanism of Action | BENLYSTA (belimumab) for Rheumatologists
Belimumab Overview - Creative Biolabs
Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus | Immunotherapy
New therapies for systemic lupus erythematosus — past imperfect, future tense | Nature Reviews Rheumatology
B-cell activating factor targeted therapy and lupus | Arthritis Research & Therapy | Full Text
Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus | Immunotherapy
Mechanism of Action | BENLYSTA (belimumab) for Rheumatologists
Belimumab - Wikipedia
The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials - ScienceDirect
Frontiers | Novel Treatments in Lupus | Immunology
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New | SpringerLink
Frontiers | A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target | Immunology
Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review
![PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d4a8c77ff85aa1fdad67620b0aea7f1405127ed2/9-Figure1-1.png "PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar")
PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar
Mechanisms of action of novel agents | Download Scientific Diagram
Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment - The Lancet
Biotherapies in systemic lupus erythematosus: New targets - ScienceDirect
Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies - The Journal of Allergy and Clinical Immunology: In Practice
